Effexor vs Cymbalta: Dosing, Side Effects, and Stopping Risk

If your prescriber has mentioned an SNRI, the choice often comes down to Effexor or Cymbalta. They’re in the same drug class and act on the same two brain chemicals, so it’s easy to assume they’re interchangeable. The trials tell a more useful story, and it shows up in your dose steps, your first weeks of side effects, your blood pressure readings, and what happens when you eventually stop.

Your nerve cells release serotonin and norepinephrine, then pull them back in through transporter proteins. Venlafaxine, the drug in Effexor, and duloxetine, the drug in Cymbalta, both block those transporters so more of each messenger stays active between cells. Where they part ways is in how each one is dosed, how long it stays in your body, and which organs clear it. Choosing between them with precision means looking at those differences one at a time.

The usual comparison lines the two drugs up by approved uses and a list of side effects. That approach rests on solid evidence. A Cochrane review found no statistically significant efficacy differences between duloxetine and the antidepressants it was compared with, including venlafaxine. An American College of Physicians review concluded that second-generation antidepressants don’t substantially differ in efficacy for major depression. The results are real, and the science is well established.

But equal efficacy on average doesn’t tell you which drug will be easier to live with, and at Siggy we think you deserve that answer before you start. A trade-off comparison puts dose flexibility, early side effects, blood pressure, liver and kidney cautions, and discontinuation risk side by side. It answers the question you actually have, which one fits your body and your life, with more precision than a class label can. The meaningful differences between Effexor and Cymbalta come from how each drug behaves in daily use.

What This Page Covers

• Effexor vs Cymbalta at a Glance
• How Dosing Differs Between Effexor and Cymbalta
• Side Effects in Head-to-Head Trials
• Blood Pressure, Liver, and Kidney Cautions
• Which One Is Harder to Stop?
• Pain, Anxiety, and Other Reasons to Choose One
• Switching Between Effexor and Cymbalta

Effexor vs Cymbalta at a Glance

This summary draws on the Effexor XR prescribing information and the Cymbalta prescribing information:

Feature	Effexor XR (Venlafaxine)	Cymbalta (Duloxetine)
Usual start for depression	75 mg, or 37.5 mg for 4 to 7 days	40 to 60 mg, or 30 mg for 1 week
Label maximum	225 mg a day for outpatients	120 mg a day
Capsule strengths	37.5, 75, and 150 mg	20, 30, and 60 mg
Half-life	About 5 hours, 11 for active metabolite	About 12 hours
FDA-approved uses	Depression, GAD, social anxiety, panic	Depression, GAD, nerve pain, fibromyalgia, musculoskeletal pain
Liver caution	Lower doses with impairment	Avoid with chronic liver disease or heavy drinking
Blood pressure checks	Recommended	Recommended

Both are usually taken once a day, so the practical differences show up in the details below.

How Dosing Differs Between Effexor and Cymbalta

Effexor XR gives your prescriber a wide range to work with. For depression, the label’s target dose is 75 mg, and increases of up to 75 mg can be made at intervals of at least 4 days, up to 225 mg a day for outpatients. How venlafaxine’s effects change across that range is covered in our guide to Effexor dosage.

Cymbalta works in a narrower band. The label recommends 40 to 60 mg a day for depression and says there’s no evidence that doses above 60 mg add benefit, even though 120 mg was shown to be effective. For generalized anxiety disorder, increases above 60 mg are allowed in 30 mg steps.

That difference shapes what happens when a medication isn’t working yet. On Effexor, the next step can be a dose increase. On Cymbalta at 60 mg, the conversation is more likely to turn to time, a different medication, or an added treatment. In the head-to-head trials described below, people started on duloxetine 60 mg or venlafaxine XR 75 mg rising to 150 mg, with later increases allowed up to 120 mg and 225 mg.

Side Effects in Head-to-Head Trials

Two pooled randomized trials compared duloxetine 60 mg with venlafaxine XR 150 mg in people with major depression. Overall benefit and risk looked similar, but the details differed. Nausea was the most common side effect for both, and it was more frequent with duloxetine during the first 6 weeks, at 43.6% versus 35.0%. More people on venlafaxine finished the 12 weeks, 74.5% versus 64.8%. The research team was based at Eli Lilly, which makes duloxetine.

The Cochrane review found a similar pattern across trials, with more people dropping out for any reason on duloxetine than on venlafaxine. Its authors noted that most included studies were industry-sponsored and that few trials existed for each comparison.

Cymbalta’s label lists nausea, dry mouth, sleepiness, constipation, decreased appetite, and sweating as its most common side effects, with nausea affecting 23% of people versus 8% on placebo. Effexor XR’s label lists nausea in 30% of people versus 12% on placebo, along with sleepiness, dry mouth, sweating, and sexual side effects. Both labels warn that sexual problems such as lower libido and delayed orgasm can happen, and our look at Cymbalta side effects separates early effects from longer-term ones.

Blood Pressure, Liver, and Kidney Cautions

A 3,744-patient analysis found venlafaxine’s effect on diastolic blood pressure was highly dose-dependent, with elevated readings becoming clinically significant only above 300 mg a day. The Effexor XR label still reports dose-related increases and cases of sustained high blood pressure at usual doses. In the head-to-head trials, 4 people on venlafaxine and none on duloxetine had sustained rises in systolic pressure during the fixed-dose period. Cymbalta’s label reports small average increases of 0.5 mm Hg systolic and 0.8 mm Hg diastolic. Both labels recommend checking your blood pressure before and during treatment.

Liver health leans the other way. The Cymbalta label describes reports of liver failure and says it shouldn’t be prescribed to people with substantial alcohol use or chronic liver disease. It also says to avoid Cymbalta in severe kidney impairment. Effexor XR’s label handles organ problems with dose cuts instead: 25% to 50% lower for mild to moderate kidney impairment, and 50% lower for mild to moderate liver impairment.

Cymbalta’s label also says to avoid potent CYP1A2 inhibitors, which can raise duloxetine levels, and notes that duloxetine moderately inhibits CYP2D6, a liver enzyme many other drugs rely on.

Which One Is Harder to Stop?

Both can cause discontinuation symptoms, and venlafaxine carries the stronger signal. A 2024 meta-analysis of 79 studies found discontinuation symptoms in 31% of people stopping an antidepressant, compared with 17% stopping placebo. Venlafaxine was among the drugs linked to more frequent symptoms, and venlafaxine or desvenlafaxine to more severe ones.

Half-life is one likely reason. Venlafaxine lasts about 5 hours and its active metabolite about 11, according to its label, while a CNS Drugs review puts duloxetine’s half-life at about 12 hours. In the head-to-head trials, significantly more people on venlafaxine reported symptoms during a 1 to 2 week taper. In Effexor XR’s own studies, doses were cut by 75 mg at 1-week intervals, and the label notes some people need several months to stop.

Duloxetine is still far from easy to stop. In pooled duloxetine trials, 44.3% of people who stopped abruptly reported discontinuation symptoms, compared with 22.9% on placebo, most often dizziness, nausea, and headache. Most people rated them mild or moderate, and the authors recommended reducing the dose over at least 2 weeks.

The capsules add a practical wrinkle. Cymbalta’s smallest capsule is 20 mg, and the label says not to open it because that may affect the coating. Effexor XR’s smallest capsule is 37.5 mg. Getting below those steps takes planning with your prescriber, which our guide to Cymbalta withdrawal walks through.

Pain, Anxiety, and Other Reasons to Choose One

Your other conditions often decide this comparison. Cymbalta is FDA-approved for diabetic nerve pain, fibromyalgia, and chronic musculoskeletal pain, along with depression and generalized anxiety disorder. Effexor XR is approved for depression, generalized anxiety disorder, social anxiety disorder, and panic disorder, with no approved pain use.

Some evidence hints at an efficacy edge for venlafaxine, though it’s indirect. An indirect trial comparison estimated venlafaxine was more effective than duloxetine, but its authors noted the absence of relevant head-to-head data at the time.

A few patterns tend to come up:

• Cymbalta may fit better if chronic pain or fibromyalgia is part of the picture, if blood pressure is a concern, or if you want a simpler dose range.
• Effexor may fit better if social anxiety or panic is a major part of the picture, if you want room to adjust the dose, or if heavy drinking or liver disease rules out Cymbalta, though liver problems still call for a lower Effexor dose.
• Either can work for depression, and how you’ve responded to medications before often tells your prescriber more than any chart.

Switching Between Effexor and Cymbalta

Neither label gives a dose conversion between the two drugs, so your prescriber builds the plan around your current dose and history.

Two risks shape that plan. Venlafaxine leaves your body quickly, so stopping it abruptly can bring on discontinuation symptoms even as the new drug starts. And both labels warn about serotonin syndrome when serotonergic drugs are combined, so any overlap needs to be deliberate and watched.

If mood worsens or you have thoughts of harming yourself during a medication change, call or text 988. If you’re in immediate danger, call 911.

The details that decide between Effexor and Cymbalta, such as early nausea, blood pressure, alcohol use, and past discontinuation symptoms, are easy to lose between visits.

Effexor offers a wider dose range and approvals for social anxiety and panic, with more blood pressure risk and a harder stop. Cymbalta offers pain approvals and a narrower dose range, with more early nausea and a firm line on liver disease and heavy drinking. If neither SNRI fits, our look at SSRI medications compared covers the main alternative class.

Ready to take control of your mental health? Start your anonymous intake with Siggy and get your plan reviewed by a licensed prescriber.

This article is for education only and isn’t a substitute for personal medical advice. Talk with your own clinician before starting, changing, or stopping any medication.